PPARGC1A and type 2 diabetes mellitus: While we corroborate the association between BCAA metabolites and type 2 diabetes [9, 26–28] and the role of PGC-1α in BCAA catabolism [15, 24, 29], we provide new evidence that an OGTT unmasks impairments in BCAA catabolism in individuals with type 2 diabetes.